<!DOCTYPE html>
<html lang="en">
    <head>
        <meta name="DC.IDENTIFIER" content="10.17917/M173-MY22  " scheme="DCTERMS.UI"><title>caNanoLab DOI Landing page</title>
        <style>
            h1 { text-align: center;}
            h2 { text-align: left;}
            table { border: 1px solid #dddddd; text-align: left; padding: 8px }
            td, th { border: 1px solid #dddddd; text-align: left; padding: 8px }
            tr:nth-child(even) { background-color: #dddddd }
        </style>
    </head><body><img src="./assets/images/crdc-logo.svg" alt="CRDC General Commons Logo"><h1> caNanoLab DOI </h1><hr><h2>NCL Method ITA-6.3: Leukocyte Proliferation Assay (Immunosuppression)</h2><hr><p>This document describes a protocol for assessing the effect of a nanoparticle formulation on the basic immunologic function of human lymphocytes, i.e. measurement of lymphocyte proliferative responses. This assay will allow for measurement of a nanoparticles‚Äô ability to suppress leukocyte proliferation induced by phytohemaglutinin (PHA-M). This protocol is a modification of part B of the NCL ITA-6.1 (formerly NCL ITA-6).</p><h3>File name: protocols/20240410_19-37-22-337_NCL_Method_ITA-6.3.pdf</h3><h3>DOI: <a href = http://dx.doi.org/10.17917/M173-MY22  >http://dx.doi.org/10.17917/M173-MY22  </a></h3><h3>Resource Type:  Protocol</h3><h3>Data Access: <a href =https://general.datacommons.cancer.gov/#/data>https://general.datacommons.cancer.gov/#/data</a></h3></body></html>